People · Operator
Named in public records as an officer, director or promoter · active 2009–2023 · Other Technology, Other, Other Energy, Hardware / Semiconductors, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ingo Money, Inc. | — | Other Technology | Series C | $91.1M | $785.5M | 2017 |
| higi SH Holdings Inc. | — | Other | Series B | $55.2M | $521.9M | 2018 |
| HLT Holdings, LLC | — | Other | Series C | $42.1M | $721.2M | 2015 |
| Halco Acquisition Corp | — | Other | Series B | $40.0M | $663.8M | 2015 |
| BTF Solutions, a Joint Venture | — | Other | Series B | $19.7M | $328.0M | 2016 |
| VeruTEK Technologies, Inc. | — | Other Technology | Seed | $5.5M | $23.4M | 2009 |
| Enduring Hydro,LLC | — | Other Energy | Seed | $3.2M | $41.3M | 2014 |
| Cerebrum Sensor Technologies Inc. | — | Hardware / Semiconductors | Seed | $2.0M | $10.5M | 2023 |
| Pointcare Technologies Inc | — | Biotechnology | Seed | $1.8M | $78.4M | 2010 |
John Collins at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Collins on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Baris Civelek | 2 | 3 |
| Jay Weaver | 2 | 2 |
| Kim Cook | 2 | 2 |
| Mark Kopaskie | 2 | 2 |
| Michael McQueeney | 2 | 2 |
| Michael Greeley | 1 | 15 |
| Glen Tullman | 1 | 12 |
| Anna Haghgooie | 1 | 11 |
| David Bailey | 1 | 11 |
| Douglas Anderson | 1 | 4 |
| Peter Neupert | 1 | 4 |
| JOHN MACK | 1 | 3 |
| Gene Lockhart | 1 | 3 |
| William Wrigley Jr. | 1 | 3 |
| Mark Ain | 1 | 2 |
| Chris Kryder | 1 | 2 |
| Fred Morris | 1 | 2 |
| Jay Holmes | 1 | 2 |
| Dickson Chu | 1 | 2 |
| Jennifer Hsin | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.